Literature DB >> 1360667

Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice.

C Mamalaki1, T Norton, Y Tanaka, A R Townsend, P Chandler, E Simpson, D Kioussis.   

Abstract

Injection of mice transgenic for a class I major histocompatibility complex-restricted T-cell receptor with a soluble peptide antigen from influenza virus nucleoprotein results in clonal depletion of double-positive immature thymocytes in the thymus and activation of mature T cells in the periphery, accompanied by a transient up-regulation of the T-cell receptor and CD3 and CD8 coreceptor molecules.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360667      PMCID: PMC50546          DOI: 10.1073/pnas.89.23.11342

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  T cell reactivity to MHC molecules: immunity versus tolerance.

Authors:  J Sprent; E K Gao; S R Webb
Journal:  Science       Date:  1990-06-15       Impact factor: 47.728

2.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

3.  The role of the T cell receptor in positive and negative selection of developing T cells.

Authors:  M Blackman; J Kappler; P Marrack
Journal:  Science       Date:  1990-06-15       Impact factor: 47.728

4.  Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity.

Authors:  S Webb; C Morris; J Sprent
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

5.  T-cell receptor-specific monoclonal antibodies against a V beta 11-positive mouse T-cell clone.

Authors:  K Tomonari; E Lovering
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo.

Authors:  K M Murphy; A B Heimberger; D Y Loh
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

7.  Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction.

Authors:  G Schönrich; U Kalinke; F Momburg; M Malissen; A M Schmitt-Verhulst; B Malissen; G J Hämmerling; B Arnold
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

Review 8.  A transgenic approach to the study of peripheral T-cell tolerance.

Authors:  J F Miller; G Morahan; J Allison; M Hoffmann
Journal:  Immunol Rev       Date:  1991-08       Impact factor: 12.988

9.  Immune recognition of HLA molecules downmodulates CD8 expression on cytotoxic T lymphocytes.

Authors:  P A Robbins; A J McMichael
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

10.  In vivo and in vitro clonal deletion of double-positive thymocytes.

Authors:  N J Vasquez; J Kaye; S M Hedrick
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

View more
  39 in total

1.  Immunostimulatory bacterial DNA sequences activate dendritic cells and promote priming and differentiation of CD8+ T cells.

Authors:  R E Tascon; S Ragno; D B Lowrie; M J Colston
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Transcriptional activation of known and novel apoptotic pathways by Nur77 orphan steroid receptor.

Authors:  Arvind Rajpal; Yuri A Cho; Biana Yelent; Petra H Koza-Taylor; Dongling Li; Elaine Chen; Michael Whang; Chulho Kang; Thomas G Turi; Astar Winoto
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

3.  The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity.

Authors:  Cristina C Clement; Aniuska Becerra; Liusong Yin; Valerio Zolla; Liling Huang; Simone Merlin; Antonia Follenzi; Scott A Shaffer; Lawrence J Stern; Laura Santambrogio
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

4.  Dendritic cell migration limits the duration of CD8+ T-cell priming to peripheral viral antigen.

Authors:  Amanda M Schell; Erica L Granger; Frank Koczot; Matthew A Fischer; Christopher C Norbury
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

5.  Interactions with multiple peptide ligands determine the fate of developing thymocytes.

Authors:  O Williams; R Tarazona; A Wack; N Harker; K Roderick; D Kioussis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

6.  Perforin and Fas cytolytic pathways coordinately shape the selection and diversity of CD8+-T-cell escape variants of influenza virus.

Authors:  Graeme E Price; Lei Huang; Rong Ou; Menghua Zhang; Demetrius Moskophidis
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis.

Authors:  R S Liblau; R Tisch; K Shokat; X Yang; N Dumont; C C Goodnow; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

8.  The influence of macrophage inflammatory protein-1alpha on protective immunity mediated by antiviral cytotoxic T cells.

Authors:  Emma Jones; David A Price; Michaela Dahm-Vicker; Vincenzo Cerundolo; Paul Klenerman; Awen Gallimore
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

9.  Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen.

Authors:  T Zal; A Volkmann; B Stockinger
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

10.  Blocked negative selection of developing T cells in mice expressing the baculovirus p35 caspase inhibitor.

Authors:  M Izquierdo; A Grandien; L M Criado; S Robles; E Leonardo; J P Albar; G G de Buitrago; C Martínez-A
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.